Monocyte/macrophage traffic and peripheral nerve pathogenesis

单核细胞/巨噬细胞交通和周围神经发病机制

基本信息

  • 批准号:
    8467482
  • 负责人:
  • 金额:
    $ 41.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-30 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Peripheral neuropathy is the most common neurological complication of HIV infection with the prevalence of neuropathy as high as 69.4% in HIV-infected patients. Increasing reports from humans highlight the contribution of macrophage activation and dorsal root ganglia (DRG) inflammation to the persistence of pathological pain in peripheral neuropathy, but the demonstration of macrophage traffic and DRG macrophages as a viral reservoir is not known. The pathogenesis of peripheral neuropathy is incompletely understood, but it is likely macrophage-mediated. In this application, we will use a SIV rhesus macaque model of AIDS to determine if: 1) continual monocyte traffic to DRGs drives peripheral neuropathy pathogenesis and effective anti-retroviral therapy (ART) will minimize this effect, 2) the ratio of M1/M2 regulatory predicts early versus chronic peripheral nerve lesions and effective ART will alter this ratio, 3) clinically relevant biomarkers (sCD163, BrdU, IENF) are linked to DRG pathology, and 4) DRG macrophages are viral reservoirs with and without ART. Successful completion of studies in this application will allow us to define: 1) monocyte/ macrophage mechanisms of DRG pathology, 2) monocyte/macrophage immune regulation during PNS disease, 3) clinical markers of peripheral nerve disease and 4) DRG macrophages as active sites of viral replication and as viral reservoirs. The overall hypothesis of the application is continual monocyte/macrophage traffic drives DRG pathogenesis and clinically relevant biomarkers and IENF effectively predict peripheral nerve pathology with and without ART. Studies in aim 1 will define the role of monocyte traffic and macrophage turnover driving PNS pathogenesis and establish a correlation between DRG damage and IENF loss with the hypothesis that monocyte traffic to DRGs mediates damage and correlates to PNS pathology. A subaim will address the hypothesis that the ratio of M1/M2 macrophages predicts early versus chronic PNS lesions. Additionally, DRG macrophages as active sites of viral replication and/or as latent viral reservoirs will be defined in this aim. Studies in aim 2 will define the role of systemic viral suppression to: 1) stop or slow PNS disease; 2) stop or slow macrophage recruitment to DRGs and 3) to clear DRG viral reservoirs. The hypothesis driving aim 2 is that systemic viral suppression by ART will slow PNS disease progression by inhibiting monocyte traffic to the DRGs and potentially clear DRG viral reservoirs. The studies described in this application provide an exciting opportunity to define the role of monocyte/macrophage traffic and macrophage activation in PNS disease and neuronal injury and the role of systemic viral immune suppression. The studies proposed here will provide new avenues of investigation into the development of therapies targeting the monocyte/macrophage in HIV peripheral neuropathy. PUBLIC HEALTH RELEVANCE: HIV-associated peripheral neuropathy is the most common neurological complication of HIV infection with prevalence as high as 69.4% in HIV-infected patients. In this application, we will use a SIV rhesus macaque model of AIDS to define the role of monocyte traffic driving peripheral nerve pathogenesis, to predict the formation of early versus chronic peripheral nerve lesions using the ratio of M1/M2 regulatory macrophages and to examine clinical biomarkers (sCD163, BrdU, IENF) linked to DRG pathology. Studies in this application will allow us to define mechanisms of DRG pathology, monocyte/macrophage immune regulation during peripheral nerve system disease and the ability of effective antiretroviral therapy to stop monocyte traffic and to clear DRG macrophage reservoirs.
描述(由申请人提供):周围神经病变是HIV感染最常见的神经系统并发症,在HIV感染患者中神经病变的患病率高达69.4%。越来越多的人类报告强调了巨噬细胞活化和背根神经节(DRG)炎症对周围神经病变中病理性疼痛持续性的贡献,但巨噬细胞运输和DRG巨噬细胞作为病毒储库的证明尚不清楚。周围神经病变的发病机制尚不完全清楚,但它可能是巨噬细胞介导的。在本申请中,我们将使用艾滋病的SIV恒河猴模型来确定是否:1)持续的单核细胞运输至DRG驱动周围神经病变发病机制,并且有效的抗逆转录病毒疗法(ART)将最小化该效应,2)M1/M2的比率调节性预测早期与慢性周围神经病变,并且有效的ART将改变该比率,3)临床相关的生物标志物(sCD 163,BrdU,IENF)与DRG病理学有关,4)DRG巨噬细胞是病毒储库,有和没有ART。成功完成本申请的研究将使我们能够确定:1)DRG病理的单核细胞/巨噬细胞机制,2)PNS疾病期间的单核细胞/巨噬细胞免疫调节,3)周围神经疾病的临床标志物和4)DRG巨噬细胞作为病毒复制的活性位点和作为病毒储库。总体假设 应用是持续的单核细胞/巨噬细胞运输驱动DRG发病机制,临床相关的生物标志物和IENF有效地预测有和没有ART的外周神经病理学。目的1的研究将确定单核细胞运输和巨噬细胞周转驱动PNS发病机制的作用,并建立DRG损伤和IENF损失之间的相关性,假设单核细胞向DRG的运输介导损伤并与PNS病理学相关。子目标将解决以下假设: 的M1/M2巨噬细胞预测早期与慢性PNS病变。此外,DRG巨噬细胞作为病毒复制的活性位点和/或作为潜伏的病毒储库将在该目的中被定义。目标2中的研究将定义全身性病毒抑制的作用:1)停止或减缓PNS疾病; 2)停止或减缓巨噬细胞向DRG募集; 3)清除DRG病毒储库。驱动目标2的假设是ART的全身性病毒抑制将通过抑制单核细胞向DRG的运输和潜在清除DRG病毒储库来减缓PNS疾病进展。本申请中描述的研究提供了一个令人兴奋的机会来定义单核细胞/巨噬细胞运输和巨噬细胞活化在PNS疾病和神经元损伤中的作用以及全身性病毒免疫抑制的作用。本文提出的研究将为开发针对HIV周围神经病变中单核细胞/巨噬细胞的治疗方法提供新的研究途径。 公共卫生关系:HIV相关性周围神经病变是HIV感染最常见的神经系统并发症,在HIV感染者中的患病率高达69.4%。在本申请中,我们将使用艾滋病的SIV恒河猴模型来定义单核细胞交通驱动外周神经发病机制的作用,使用M1/M2调节性巨噬细胞的比率来预测早期与慢性外周神经病变的形成,并检查与DRG病理学相关的临床生物标志物(sCD 163、BrdU、IENF)。本申请的研究将使我们能够确定DRG病理学机制、外周神经系统疾病期间单核细胞/巨噬细胞免疫调节以及有效抗逆转录病毒治疗阻止单核细胞运输和清除DRG巨噬细胞储库的能力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tricia Helen Burdo其他文献

Tricia Helen Burdo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tricia Helen Burdo', 18)}}的其他基金

CRISPR for Cure
CRISPR 治愈
  • 批准号:
    10619015
  • 财政年份:
    2021
  • 资助金额:
    $ 41.98万
  • 项目类别:
CRISPR for Cure
CRISPR 治愈
  • 批准号:
    10313361
  • 财政年份:
    2021
  • 资助金额:
    $ 41.98万
  • 项目类别:
CRISPR for Cure
CRISPR 治愈
  • 批准号:
    10469440
  • 财政年份:
    2021
  • 资助金额:
    $ 41.98万
  • 项目类别:
Role of caspase-1 activation in HIV-1 associated atherogenesis
Caspase-1 激活在 HIV-1 相关动脉粥样硬化形成中的作用
  • 批准号:
    10162645
  • 财政年份:
    2018
  • 资助金额:
    $ 41.98万
  • 项目类别:
Role of caspase-1 activation in HIV-1 associated atherogenesis
Caspase-1 激活在 HIV-1 相关动脉粥样硬化形成中的作用
  • 批准号:
    9923758
  • 财政年份:
    2018
  • 资助金额:
    $ 41.98万
  • 项目类别:
Role of caspase-1 activation in HIV-1 associated atherogenesis
Caspase-1 激活在 HIV-1 相关动脉粥样硬化形成中的作用
  • 批准号:
    9751953
  • 财政年份:
    2018
  • 资助金额:
    $ 41.98万
  • 项目类别:
Monocyte/macrophage traffic and peripheral nerve pathogenesis
单核细胞/巨噬细胞交通和周围神经发病机制
  • 批准号:
    9088512
  • 财政年份:
    2012
  • 资助金额:
    $ 41.98万
  • 项目类别:
Monocyte/macrophage traffic and peripheral nerve pathogenesis
单核细胞/巨噬细胞交通和周围神经发病机制
  • 批准号:
    8666090
  • 财政年份:
    2012
  • 资助金额:
    $ 41.98万
  • 项目类别:
Monocyte/macrophage traffic and peripheral nerve pathogenesis
单核细胞/巨噬细胞交通和周围神经发病机制
  • 批准号:
    8554929
  • 财政年份:
    2012
  • 资助金额:
    $ 41.98万
  • 项目类别:
Component for Institution # 269291
机构组件
  • 批准号:
    10475407
  • 财政年份:
    2011
  • 资助金额:
    $ 41.98万
  • 项目类别:

相似海外基金

Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334970
  • 财政年份:
    2024
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
  • 批准号:
    2400195
  • 财政年份:
    2024
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
  • 批准号:
    2334969
  • 财政年份:
    2024
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
  • 批准号:
    23K04919
  • 财政年份:
    2023
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
  • 批准号:
    22KJ2957
  • 财政年份:
    2023
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
  • 批准号:
    23K04494
  • 财政年份:
    2023
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
  • 批准号:
    23K13831
  • 财政年份:
    2023
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
  • 批准号:
    2238379
  • 财政年份:
    2023
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
  • 批准号:
    2154399
  • 财政年份:
    2022
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
  • 批准号:
    RGPIN-2019-06633
  • 财政年份:
    2022
  • 资助金额:
    $ 41.98万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了